Company Filing History:
Years Active: 2024-2025
Title: Dallas Benjamin Flies: Innovator in Immunomodulatory Agents
Introduction
Dallas Benjamin Flies is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of immunology through his innovative patents. With a total of 2 patents to his name, Flies is recognized for his work in developing immunomodulatory agents that can influence immune responses.
Latest Patents
Flies' latest patents include "B7-H4 antibodies and methods of use thereof" and "Compositions and methods for modulating LAIR signal transduction." The first patent provides compositions and methods for modulating B7-H4, which can either increase or decrease immune responses in subjects. The second patent focuses on LAIR-1 modulation, offering agents that can enhance or inhibit immune responses, depending on the needs of the subject.
Career Highlights
Dallas Benjamin Flies is currently associated with Nextcure, Inc., where he continues to advance his research in immunology. His work has the potential to lead to significant advancements in therapeutic strategies for various immune-related conditions.
Collaborations
Flies collaborates with esteemed colleagues such as Solomon Langermann and Linda Liu, contributing to a dynamic research environment that fosters innovation.
Conclusion
Dallas Benjamin Flies is a prominent figure in the field of immunology, with a focus on developing novel immunomodulatory agents. His contributions through patents and collaborations highlight his commitment to advancing medical science.